Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLOPATADINE for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 5 adverse event reports in the FDA FAERS database where OLOPATADINE was used for Psoriasis.

Most Reported Side Effects for OLOPATADINE

Side Effect Reports % Deaths Hosp.
Treatment failure 4,685 53.3% 0 1
Drug ineffective 1,600 18.2% 0 8
Eye irritation 554 6.3% 0 1
Vision blurred 368 4.2% 0 1
Eye pruritus 317 3.6% 0 4
Hypersensitivity 269 3.1% 46 67
Ocular hyperaemia 260 3.0% 1 2
Eye pain 228 2.6% 0 1
Eye discharge 225 2.6% 0 2
Eye swelling 143 1.6% 0 3
Dry eye 132 1.5% 0 0
Lacrimation increased 128 1.5% 0 3
Condition aggravated 116 1.3% 0 4
Headache 106 1.2% 0 3
Ocular discomfort 95 1.1% 0 0

Other Indications for OLOPATADINE

Product used for unknown indication (7,164) Eye pruritus (396) Eye allergy (344) Conjunctivitis allergic (318) Hypersensitivity (187) Dry eye (94) Ocular hyperaemia (89) Pruritus (65) Eye irritation (51) Seasonal allergy (46)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

OLOPATADINE Full Profile All Psoriasis Drugs OLOPATADINE Demographics OLOPATADINE Timeline